Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patient affordability
Pharma
ICER, West Health call out excessive U.S. drug launch prices
From a starting rate of $190,000 in 2022, the median net launch price of U.S. drugs jumped up 35% by 2025, a new ICER and West Health report claims.
Fraiser Kansteiner
Oct 21, 2026 10:36am
JEC Democrats scrutinize Trump's soaring pharma holdings
Oct 16, 2026 2:50pm
How biosimilar developers are embracing next phase of US market
Jul 6, 2026 10:03am
TrumpRx site updated to include hundreds of generic medications
May 19, 2026 11:04am
Hims uses new Super Bowl ad to tackle healthcare affordability
Jan 29, 2026 1:39pm